Remedent Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Remedent's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment Industry Growth	8.9%
Revenue growth rate	n/a
Return on equity	n/a
Net Margin	n/a
Last Earnings Update	31 Mar 2023

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Remedent makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:REMI Revenue, expenses and earnings (EUR Millions)
Date	Revenue	Earnings	G+A Expenses
31 Mar 23	0	0	1
31 Mar 22	0	0	0
31 Mar 21	0	0	0
31 Dec 20	1	0	1
30 Sep 20	1	0	1
30 Jun 20	1	-1	1
31 Mar 20	0	0	1
31 Dec 19	1	2	1
30 Sep 19	1	2	1
30 Jun 19	1	2	1
31 Mar 19	1	2	2
31 Dec 18	1	-1	2
30 Sep 18	2	0	2
30 Jun 18	2	0	2
31 Mar 18	2	0	2
31 Dec 17	2	1	2
30 Sep 17	2	1	2
30 Jun 17	2	1	2
31 Mar 17	2	1	2
31 Dec 16	2	0	2
30 Sep 16	2	0	2
30 Jun 16	2	0	2
31 Mar 16	2	0	2
31 Dec 15	3	0	2
30 Sep 15	3	0	1
30 Jun 15	3	0	2
31 Mar 15	3	0	2
31 Dec 14	2	0	2
30 Sep 14	2	0	2
30 Jun 14	2	0	2
31 Mar 14	2	0	1

Quality Earnings: Insufficient data to determine if REMI has high quality earnings.

Growing Profit Margin: Insufficient data to determine if REMI's profit margins have improved over the past year.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if REMI's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare REMI's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if REMI's earnings growth over the past year exceeded the Medical Equipment industry average.

Return on Equity

High ROE: REMI has a negative Return on Equity (0%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/07 12:09
End of Day Share Price	2025/01/22 00:00
Earnings	2023/03/31
Annual Earnings	2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Remedent, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.